Nonobese diabetic (NOD) mice congenic for a targeted deletion of 12/15-lipoxygenase are protected from autoimmune diabetes

Diabetes

Volumn 57, Issue 1, 2008, Pages 199-208

  McDuffie, Marcia ^a   Maybee, Nelly A ^a   Keller, Susanna R ^a   Stevens, Brian K ^a   Garmey, James C ^a   Morris, Margaret A ^a   Kropf, Elizabeth ^a   Rival, Claudia ^a   Ma, Kaiwen ^a   Carter, Jeffrey D ^a   Tersey, Sarah A ^a   Nunemaker, Craig S ^a   Nadler, Jerry L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; 12 15 LIPOXYGENASE; 12-15-LIPOXYGENASE; DNA; PRIMER DNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; GENE DELETION; GENE LOCATION; GENE TARGETING; GLUCOSE TOLERANCE TEST; INCIDENCE; MALE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; ANIMAL; CHROMOSOME MAP; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; GENOME; GLUCOSURIA; INSULIN DEPENDENT DIABETES MELLITUS; ISOLATION AND PURIFICATION; LIVER; MACROPHAGE ACTIVATION; TAIL;

ANIMALS; ARACHIDONATE 12-LIPOXYGENASE; ARACHIDONATE 15-LIPOXYGENASE; CHROMOSOME MAPPING; DIABETES MELLITUS, TYPE 1; DNA; DNA PRIMERS; GENETIC PREDISPOSITION TO DISEASE; GENOME; GLYCOSURIA; LIVER; MACROPHAGE ACTIVATION; MICE; MICE, INBRED NOD; SEQUENCE DELETION; TAIL;

EID: 38449098081     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-0830     Document Type: Article

References (55)

1. Atkinson MA, Leiter EH: The NOD mouse model of type 1 diabetes: as good as it gets? Nat Med 5:601-604, 1999
2. Maier LM, Wicker LS: Genetic susceptibility to type 1 diabetes. Curr Opin Immunol 17:601-608, 2005
3. Todd JA, Aitman TJ, Cornall RJ, Ghosh S, Hall JR, Hearne CM, Knight AM, Love JM, McAleer MA, Prins JB: Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature 351:542-547, 1991
4. Ivakine EA, Fox CJ, Paterson AD, Mortin-Toth SM, Canty A, Walton DS, Aleksa K, Ito S, Danska JS: Sex-specific effect of insulin-dependent diabetes 4 on regulation of diabetes pathogenesis in the nonobese diabetic mouse. J Immunol 174:7129-7140, 2005
5. McDuffie M: Derivation of diabetes-resistant congenic lines from the nonobese diabetic mouse. Clin Immunol 96:119-130, 2000
6. Litherland SA, Grebe KM, Belkin NS, Paek E, Elf J, Atkinson M, Morel L, Clare-Salzler MJ, McDuffie M: Nonobese diabetic mouse congenic analysis reveals chromosome 11 locus contributing to diabetes susceptibility, macrophage STAT5 dysfunction, and granulocyte-macrophage colony-stimulating factor overproduction. J Immunol 175:4561-4565, 2005
7. Grattan M, Mi QS, Meagher C, Delovitch TL: Congenic mapping of the diabetogenic locus Idd4 to a 5.2-cM region of chromosome 11 in NOD mice: identification of two potential candidate subloci. Diabetes 51:215-223, 2002
8. Ivakine EA, Mortin-Toth SM, Gulban OM, Valova A, Canty A, Scott C, Danska JS: The idd4 locus displays sex-specific epistatic effects on type 1 diabetes susceptibility in nonobese diabetic mice. Diabetes 55:3611-3619, 2006
9. Davoodi-Semiromi A, Laloraya M, Kumar GP, Purohit S, Jha RK, She JX: A mutant Stat5b with weaker DNA binding affinity defines a key defective pathway in nonobese diabetic mice. J Biol Chem 279:11553-11561, 2004
10. Laloraya M, voodi-Semiromi A, Kumar GP, McDuffie M, She JX: Impaired Crkl expression contributes to the defective DNA binding of Stat5b in nonobese diabetic mice. Diabetes 55:734-741, 2006
11. Ymer SI, Huang D, Penna G, Gregori S, Branson K, Adorini L, Morahan G: Polymorphisms in the Il12b gene affect structure and expression of IL-12 in NOD and other autoimmune-prone mouse strains. Genes Immun 3:151-157, 2002
12. Chen XS, Kurre U, Jenkins NA, Copeland NG, Funk CD: cDNA cloning, expression, mutagenesis of C-terminal isoleucine, genomic structure, and chromosomal localizations of murine 12-lipoxygenases. J Biol Chem 269:13979-13987, 1994
13. Chen M, Yang ZD, Smith KM, Carter JD, Nadler JL: Activation of 12-lipoxygenase in proinflammatory cytokine-mediated beta cell toxicity. Diabetologia 48:486-495, 2005
14. Soberman RJ, Harper TW, Betteridge D, Lewis RA, Austen KF: Characterization and separation of the arachidonic acid 5-lipoxygenase and linoleic acid omega-6 lipoxygenase (arachidonic acid 15-lipoxygenase) of human polymorphonuclear leukocytes. J Biol Chem 260:4508-4515, 1985
15. Yamamoto S, Nishimura M, Conners MS, Stoltz RA, Falck JR, Chauhan K, Laniado-Schwartzman M: Oxidation and keto reduction of 12-hydroxy-5,8,10,14- eicosatetraenoic acids in bovine corneal epithelial microsomes. Biochim Biophys Acta 1210:217-225, 1994
16. Jarpe AJ, Hickman MR, Anderson JT, Winter WE, Peck AB: Flow cytometric enumeration of mononuclear cell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of a model of autoimmune insulitis for type I diabetes. Reg Immunol 3:305-317, 1990
17. Reddy S, Liu W, Elliott RB: Distribution of pancreatic macrophages preceding and during early insulitis in young NOD mice. Pancreas 8:602-608, 1993
18. Charre S, Rosmalen JG, Pelegri C, Alves V, Leenen PJ, Drexhage HA, Homo-Delarche F: Abnormalities in dendritic cell and macrophage accumulation in the pancreas of nonobese diabetic (NOD) mice during the early neonatal period. Histol Histopathol 17:393-401, 2002
19. Jansen A, Homo-Delarche F, Hooijkaas H, Leenen PJ, Dardenne M, Drexhage HA: Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and β-cell destruction in NOD mice. Diabetes 43:667-675, 1994
20. Rosmalen JG, Homo-Delarche F, Durant S, Kap M, Leenen PJ, Drexhage HA: Islet abnormalities associated with an early influx of dendritic cells and macrophages in NOD and NODscid mice. Lab Invest 80:769-777, 2000
21. Rosmalen JG, Martin T, Dobbs C, Voerman JS, Drexhage HA, Haskins K, Leenen PJ: Subsets of macrophages and dendritic cells in nonobese diabetic mouse pancreatic inflammatory infiltrates: correlation with the development of diabetes. Lab Invest 80:23-30, 2000
22. Serreze DV, Gaedeke JW, Leiter EH: Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C. Proc Natl Acad Sci U S A 90:9625-9629, 1993
23. Langmuir PB, Bridgett MM, Bothwell AL, Crispe IN: Bone marrow abnormalities in the non-obese diabetic mouse. Int Immunol 5:169-177, 1993
24. Alleva DG, Pavlovich RP, Grant C, Kaser SB, Beller DI: Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor- and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice. Diabetes 49:1106-1115, 2000
25. Liu J, Beller DI: Distinct pathways for NF-kappa B regulation are associated with aberrant macrophage IL-12 production in lupus- and diabetes-prone mouse strains. J Immunol 170:4489-4496, 2003
26. Maree AF, Komba M, Dyck C, Labecki M, Finegood DT, Edelstein-Keshet L: Quantifying macrophage defects in type 1 diabetes. J Theor Biol 233:533-551, 2005
27. Nikolic T, Bunk M, Drexhage HA, Leenen PJ: Bone marrow precursors of nonobese diabetic mice develop into defective macrophage-like dendritic cells in vitro. J Immunol 173:4342-4351, 2004
28. Stoffels K, Overbergh L, Giulietti A, Kasran A, Bouillon R, Gysemans C, Mathieu C: NOD macrophages produce high levels of inflammatory cytokines upon encounter of apoptotic or necrotic cells. J Autoimmun 23:9-15, 2004
29. Nikolic T, Bouma G, Drexhage HA, Leenen PJ: Diabetes-prone NOD mice show an expanded subpopulation of mature circulating monocytes, which preferentially develop into macrophage-like cells in vitro. J Leukoc Biol 78:70-79, 2005
30. O'Brien BA, Geng X, Orteu CH, Huang Y, Ghoreishi M, Zhang Y, Bush JA, Li G, Finegood DT, Dutz JP: A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse. J Autoimmun 26:104-115, 2006
31. Middleton MK, Rubinstein T, Pure E: Cellular and molecular mechanisms of the selective regulation of IL-12 production by 12/15-lipoxygenase. J Immunol 176:265-274, 2006
32. Bleich D, Chen S, Gu JL, Thomas L, Scott S, Gonzales N, Natarajan R, Nadler JL: Interleukin-1 beta regulates the expression of a leukocyte type of 12-lipoxygenase in rat islets and RIN m5F cells. Endocrinology 136:5736-5744, 1995
33. Ma Z, Ramanadham S, Corbett JA, Bohrer A, Gross RW, McDaniel ML, Turk J: Interleukin-1 enhances pancreatic islet arachidonic acid 12-lipoxygenase product generation by increasing substrate availability through a nitric oxide-dependent mechanism. J Biol Chem 271:1029-1042, 1996
34. Bleich D, Chen S, Wen Y, Nadler JL: The stress-activated c-Jun protein kinase (JNK) is stimulated by lipoxygenase pathway product 12-HETE in RIN m5F cells. Biochem Biophys Res Commun 230:448-451, 1997
35. Cyrus T, Witztum JL, Rader DJ, Tangirala R, Fazio S, Linton MF, Funk CD: Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J Clin Invest 103:1597-1604, 1999
36. Bleich D, Chen S, Zipser B, Sun D, Funk CD, Nadler JL: Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice. J Clin Invest 103:1431-1436, 1999
37. Sun D, Funk CD: Disruption of 12/15-lipoxygenase expression in peritoneal macrophages: enhanced utilization of the 5-lipoxygenase pathway and diminished oxidation of low density lipoprotein. J Biol Chem 271:24055-24062, 1996
38. Dietrich WF, Miller J, Steen R, Merchant MA, Mron-Boles D, Husain Z, Dredge R, Daly MJ, Ingalls KA, O'Connor TJ: A comprehensive genetic map of the mouse genome. Nature 380:149-152, 1996
39. George J, Afek A, Shaish A, Levkovitz H, Bloom N, Cyrus T, Zhao L, Funk CD, Sigal E, Harats D: 12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice. Circulation 104:1646-1650, 2001
40. Reilly KB, Srinivasan S, Hatley ME, Patricia MK, Lannigan J, Bolick DT, Vandenhoff G, Pei H, Natarajan R, Nadler JL, Hedrick CC: 12/15-Lipoxygenase activity mediates inflammatory monocyte/endothelial interactions and atherosclerosis in vivo. J Biol Chem 279:9440-9450, 2004
41. Yang Z, Chen M, Ellett JD, Fialkow LB, Carter JD, McDuffie M, Nadler JL: Autoimmune diabetes is blocked in Stat4-deficient mice. J Autoimmun 22:191-200, 2004
42. Ivakine EA, Gulban OM, Mortin-Toth SM, Wankiewicz E, Scott C, Spurrell D, Canty A, Danska JS: Molecular genetic analysis of the Idd4 locus implicates the IFN response in type 1 diabetes susceptibility in nonobese diabetic mice. J Immunol 176:2976-2990, 2006
43. Razavi R, Chan Y, Afifiyan FN, Liu XJ, Wan X, Yantha J, Tsui H, Tang L, Tsai S, Santamaria P, Driver JP, Serreze D, Salter MW, Dosch HM: TRPV1+ sensory neurons control beta cell stress and islet inflammation in autoimmune diabetes. Cell 127:1123-1135, 2006
44. Bour-Jordan H, Bluestone JA: Sensory neurons link the nervous system and autoimmune diabetes. Cell 127:1097-1099, 2006
45. Leiter EH: The Jackson Laboratory. Available from http://www.jax.org/ t1dr/images/5311-5312-5313-idd-sweep-and-chr1-and-11-scan.jpg. Accessed 9 November 2006
46. Bluestone JA, Tang Q: Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells. Proc Natl Acad Sci U S A 101 (Suppl. 2):14622-14626, 2004
47. Huang JT, Welch JS, Ricote M, Binder CJ, Willson TM, Kelly C, Witztum JL, Funk CD, Conrad D, Glass CK: Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature 400:378-382, 1999
48. Falcone M, Yeung B, Tucker L, Rodriguez E, Krahl T, Sarvetnick N: IL-4 triggers autoimmune diabetes by increasing self-antigen presentation within the pancreatic islets. Clin Immunol 98:190-199, 2001
49. Ho SH, Lee HJ, Kim DS, Jeong JG, Kim S, Yu SS, Jin Z, Kim S, Kim JM: Intrasplenic electro-transfer of IL-4 encoding plasmid DNA efficiently inhibits rat experimental allergic encephalomyelitis. Biochem Biophys Res Commun 343:816-824, 2006
50. Emerson MR, LeVine SM: Experimental allergic encephalomyelitis is exacerbated in mice deficient for 12/15-lipoxygenase or 5-lipoxygenase. Brain Res 1021:140-145, 2004
51. Thakker P, Leach MW, Kuang W, Benoit SE, Leonard JP, Marusic S: IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis. J Immunol 178:2589-2598, 2007
52. Bleich D, Chen S, Gu JL, Nadler JL: The role of 12-lipoxygenase in pancreatic-cells (Review). Int J Mol Med 1:265-272, 1998
53. Wen Y, Gu J, Chakrabarti SK, Aylor K, Marshall J, Takahashi Y, Yoshimoto T, Nadler JL: The role of 12/15-lipoxygenase in the expression of interleukin-6 and tumor necrosis factor-alpha in macrophages. Endocrinology 148:1313-1322, 2007
54. Im JY, Han PL: Nordihydroguaiaretic acid induces astroglial death via glutathione depletion. J Neurosci Res 85:3127-3134, 2007
55. Fujimoto Y, Ikeda M, Sakuma S: Monochloramine potently inhibits arachidonic acid metabolism in rat platelets. Biochem Biophys Res Commun 344:140-145, 2006